Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 1997

View Archived Issues

Naratriptan highlighted at headache congress; introduced in U.K.

Novel melatonergic agents described by Bristol-Myers Squibb

Encouraging data reported for Sugen's insulin phosphatase inhibitors

Kyowa Hakko claims compounds for thrombocytopenia

FDA advisory committee withholds recommendation of Ilex Oncology's treatment for AIDS-related NHL

Ono describes elastase inhibitors

P&U prepares inhibitors of kynurenine 3-hydroxylase for neurodegenerative diseases

U.S. patents issued to Yale University and Innovir for EGS technology

Selective dopamine D3 receptor ligands from Novo Nordisk

MS&D prepares potent and selective 5-HT1D agonists

Neurogen and Tularik sign drug discovery agreement

Protein farnesyltransferase inhibitors from Janssen

Megabios issued patent for aerosol gene delivery system

Efficacy of SB-206284A in animal models of cerebral ischemia

Positive efficacy profile for MacroChem's erectile dysfunction therapy

Univ. of Tokyo scientists isolate potent and selective papain inhibitor

Abbott selects new motilide as candidate for GI motility disorders

Potential new antidiabetic and antiobesity agent from Dainippon

Case report of congenital abnormalities associated with maternal methotrexate ingestion

Valaciclovir vs. placebo for recurrent genital HSV

NMDA antagonists improve memory deficits after brain injury in the rat

Hypolipidemic effects of F-1394 in hyperlipidemic dogs

Antipruritogenic effect of Kochia Fructus extract and active components

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...